Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
malaria vaccine
|
| gptkbp:administeredBy |
injection
|
| gptkbp:clinicalTrialsConductedIn |
gptkb:Africa
gptkb:Asia gptkb:South_America |
| gptkbp:composition |
synthetic peptides from Plasmodium falciparum proteins
|
| gptkbp:developedBy |
gptkb:Colombia
gptkb:Manuel_Elkin_Patarroyo |
| gptkbp:effect |
variable
generally low in Africa higher in South America |
| gptkbp:firstTestedIn |
1987
|
| gptkbp:goal |
prevent malaria infection
|
| https://www.w3.org/2000/01/rdf-schema#label |
SPf66 malaria vaccine
|
| gptkbp:notableFor |
first synthetic malaria vaccine tested in humans
|
| gptkbp:notLicensedFor |
widespread use
|
| gptkbp:target |
gptkb:Plasmodium_falciparum
|
| gptkbp:type |
synthetic peptide vaccine
|
| gptkbp:bfsParent |
gptkb:Manuel_Elkin_Patarroyo
|
| gptkbp:bfsLayer |
6
|